Wave Life Sciences
WVE
49 hedge funds and large institutions have $432M invested in Wave Life Sciences in 2017 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 19 increasing their positions, 13 reducing their positions, and 5 closing their positions.
46% more repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 13
40% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 5
11% more capital invested
Capital invested by funds: $388M → $432M (+$43.5M)
3.61% more ownership
Funds ownership: 63.13% → 66.74% (+3.6%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
4% less funds holding
Funds holding: 51 → 49 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$9.61M |
| 2 |
BlackRock
New York
|
+$9.38M |
| 3 |
RG
Redmile Group
San Francisco,
California
|
+$8.92M |
| 4 |
CCP
Clough Capital Partners
Boston,
Massachusetts
|
+$5.5M |
| 5 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$2.19M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$2.75M |
| 2 |
Marshall Wace
London,
United Kingdom
|
-$780K |
| 3 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$721K |
| 4 |
Renaissance Technologies
New York
|
-$403K |
| 5 |
Morgan Stanley
New York
|
-$318K |
WVE Hedge Fund Activity: Q1 2017 in Review
49 of the 4,034 institutional investors tracked by Wall St. Rank reported a position in Wave Life Sciences (WVE) for Q1 2017, worth a combined $432M — up 11% from $388M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new WVE positions and 5 closed out — a net gain of 2 holders — while 19 added to existing stakes and 13 trimmed.
The largest buyer was T. Rowe Price Associates, adding an estimated $9.61M. The largest seller was Fidelity Investments, cutting an estimated $2.75M.
- 49 institutional investors held Wave Life Sciences (WVE) as of Q1 2017, down from 51 in Q4 2016.
- Funds reported $432M of Wave Life Sciences stock for Q1 2017, up 11% quarter-over-quarter.
- 7 funds opened new Wave Life Sciences positions in Q1 2017 and 5 closed out, a net change of +2 holders.
- The largest Wave Life Sciences buyer in Q1 2017 was T. Rowe Price Associates, an estimated $9.61M added.
- The largest Wave Life Sciences seller in Q1 2017 was Fidelity Investments, an estimated $2.75M sold.
Based on aggregated 13F filings for Q1 2017.